×
戻る Agenda
Session 6, Track A: Advancing Clinical Trials in Latin America - Regulatory Alignment for Decentralized and Innovative Study Designs
Session Chair(s)
Priscila De Lara Fagundes Esteves, RPH
Director Regulatory Affairs , PPD Clinical Research Services, Thermo Fisher Scientific, Brazil
Monica Lizano, MD, MBA
Global Director, Clinical Quality Management, Merck Chile, Chile
Session 6, Track A: Advancing Clinical Trials in Latin America - Regulatory Alignment for Decentralized and Innovative Study Designs
Learning Objective : Describe regulatory opportunities in Latin America to support community-based and decentralized trial models. Analyze Latin American regulatory approaches to digital-health–enabled participation, remote oversight, and global harmonization for clinical trials. Identify regulatory policy strategies that enhance inclusion, patient access, and trial data.
Speaker(s)
Representative Invited
Manager, Global Regulatory Policy & Strategy, Eli Lilly and Company, United States
From Community to Region: Strengthening Latin American Regulatory Pathways for Decentralized Clinical Trials